157 related articles for article (PubMed ID: 35794947)
21. High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa.
Castillo-Mancilla JR; Musinguzi N; Asiimwe S; Siedner MJ; Orrell C; Bangsberg DR; Haberer JE
HIV Med; 2022 May; 23(5):465-473. PubMed ID: 34704355
[TBL] [Abstract][Full Text] [Related]
22. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
24. Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome.
Varona JF; Ortiz-Regalón R; Sánchez-Vera I; López-Melgar B; García-Durango C; Castellano Vázquez JM; Solís J; Fernández-Friera L; Vidal-Vanaclocha F
Arch Med Res; 2019 Feb; 50(2):20-28. PubMed ID: 31349950
[TBL] [Abstract][Full Text] [Related]
25. Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness.
SahBandar IN; Ndhlovu LC; Saiki K; Kohorn LB; Peterson MM; D'Antoni ML; Shiramizu B; Shikuma CM; Chow DC
J Atheroscler Thromb; 2020 May; 27(5):441-448. PubMed ID: 31588100
[TBL] [Abstract][Full Text] [Related]
26. Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection.
Graham SM; Nance RM; Chen J; Wurfel MM; Hunt PW; Heckbert SR; Budoff MJ; Moore RD; Jacobson JM; Martin JN; Crane HM; López JA; Liles WC
J Acquir Immune Defic Syndr; 2023 Aug; 93(4):282-291. PubMed ID: 37018921
[TBL] [Abstract][Full Text] [Related]
27. Carotid intima-media thickness: knowledge and application to everyday practice.
Cobble M; Bale B
Postgrad Med; 2010 Jan; 122(1):10-8. PubMed ID: 20107284
[TBL] [Abstract][Full Text] [Related]
28. Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic Review.
Polanka BM; Gupta SK; So-Armah KA; Freiberg MS; Zapolski TCB; Hirsh AT; Stewart JC
Ann Behav Med; 2023 Jan; 57(1):1-25. PubMed ID: 35481701
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment.
Vos AG; Hoeve K; Barth RE; Peper J; Moorhouse M; Crowther NJ; Venter WDF; Grobbee DE; Bots ML; Klipstein-Grobusch K
Retrovirology; 2019 Dec; 16(1):37. PubMed ID: 31796103
[TBL] [Abstract][Full Text] [Related]
30. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.
Basurto L; Gregory MA; Hernández SB; Sánchez-Huerta L; Martínez AD; Manuel-Apolinar L; Avelar FJ; Alonso LAM; Sánchez-Arenas R
Exp Gerontol; 2019 Sep; 124():110624. PubMed ID: 31152776
[TBL] [Abstract][Full Text] [Related]
31. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
32. Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study.
Polanka BM; Kundu S; So-Armah KA; Freiberg MS; Gupta SK; Zapolski TCB; Hirsh AT; Bedimo RJ; Budoff MJ; Butt AA; Chang CH; Gottlieb SS; Marconi VC; Womack JA; Stewart JC
PLoS One; 2021; 16(2):e0246073. PubMed ID: 33561176
[TBL] [Abstract][Full Text] [Related]
33. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.
Rajasuriar R; Kong YY; Nadarajah R; Abdullah NK; Spelman T; Yuhana MY; Ponampalavanar S; Kamarulzaman A; Lewin SR
J Transl Med; 2015 Jan; 13():30. PubMed ID: 25622527
[TBL] [Abstract][Full Text] [Related]
34. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.
Vos AG; Dodd CN; Delemarre EM; Nierkens S; Serenata C; Grobbee DE; Klipstein-Grobusch K; Venter WDF
Front Immunol; 2021; 12():647805. PubMed ID: 34290695
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.
Gooden TE; Gardner M; Wang J; Jolly K; Lane DA; Benjamin LA; Mwandumba HC; Kandoole V; Lwanga IB; Taylor S; Manaseki-Holland S; Lip GYH; Nirantharakumar K; Thomas GN
J Infect Dis; 2022 Apr; 225(8):1348-1356. PubMed ID: 34417792
[TBL] [Abstract][Full Text] [Related]
36. Traditional risk factors are more relevant than HIV-specific ones for carotid intima-media thickness (cIMT) in a Brazilian cohort of HIV-infected patients.
Pacheco AG; Grinsztejn B; da Fonseca Mde J; Moreira RI; Veloso VG; Friedman RK; Santini-Oliveira M; Cardoso SW; Falcão M; Mill JG; Bensenor I; Lotufo P; Chor D
PLoS One; 2015; 10(2):e0117461. PubMed ID: 25692764
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.
Funderburg NT; Shive CL; Chen Z; Tatsuoka C; Bowman ER; Longenecker CT; McComsey GA; Clagett BM; Dorazio D; Freeman ML; Sieg SF; Moisi D; Anthony DD; Jacobson JM; Stein SL; Calabrese LH; Landay A; Flexner C; Crawford KW; Capparelli EV; Rodriguez B; Lederman MM
Clin Infect Dis; 2023 Jul; 77(2):272-279. PubMed ID: 37011013
[TBL] [Abstract][Full Text] [Related]
38. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.
Grunfeld C; Delaney JA; Wanke C; Currier JS; Scherzer R; Biggs ML; Tien PC; Shlipak MG; Sidney S; Polak JF; O'Leary D; Bacchetti P; Kronmal RA
AIDS; 2009 Sep; 23(14):1841-9. PubMed ID: 19455012
[TBL] [Abstract][Full Text] [Related]
39. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
Parra S; Coll B; Aragonés G; Marsillach J; Beltrán R; Rull A; Joven J; Alonso-Villaverde C; Camps J
HIV Med; 2010 Apr; 11(4):225-31. PubMed ID: 19845792
[TBL] [Abstract][Full Text] [Related]
40. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
